131 related articles for article (PubMed ID: 9371242)
1. N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.
Van Calenbergh S; von Frijtag Drabbe Künzel JK; Blaton NM; Peeters OM; Rozenski J; Van Aerschot A; De Bruyn A; De Keukeleire D; IJzerman AP; Herdewijn P
J Med Chem; 1997 Nov; 40(23):3765-72. PubMed ID: 9371242
[TBL] [Abstract][Full Text] [Related]
2. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.
van der Wenden EM; Carnielli M; Roelen HC; Lorenzen A; von Frijtag Drabbe Künzel JK; IJzerman AP
J Med Chem; 1998 Jan; 41(1):102-8. PubMed ID: 9438026
[TBL] [Abstract][Full Text] [Related]
3. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
4. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
[TBL] [Abstract][Full Text] [Related]
6. N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.
Roelen H; Veldman N; Spek AL; von Frijtag Drabbe Künzel J; Mathôt RA; IJzerman AP
J Med Chem; 1996 Mar; 39(7):1463-71. PubMed ID: 8691477
[TBL] [Abstract][Full Text] [Related]
7. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
Dalpiaz A; Gessi S; Varani K; Borea PA
Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
[TBL] [Abstract][Full Text] [Related]
8. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
[TBL] [Abstract][Full Text] [Related]
9. 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.
de Zwart M; Kourounakis A; Kooijman H; Spek AL; Link R; von Frijtag Drabbe Künzel JK; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1384-92. PubMed ID: 10212124
[TBL] [Abstract][Full Text] [Related]
10. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
[TBL] [Abstract][Full Text] [Related]
12. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
[TBL] [Abstract][Full Text] [Related]
13. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
Yan L; Müller CE
J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
[TBL] [Abstract][Full Text] [Related]
14. Development of spin-labeled probes for adenosine receptors.
Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
16. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
[TBL] [Abstract][Full Text] [Related]
17. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
18. Amino-substituted 1,8-naphthyridines and pyrido[2,3-d]pyrimidines: new compounds with affinity for A1- and A2-adenosine receptors.
Müller CE; Grahner B; Heber D
Pharmazie; 1994 Dec; 49(12):878-80. PubMed ID: 7838877
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the effects of N6-cyclopentyladenosine analogs on heart rate in rat: estimation of in vivo operational affinity and efficacy at adenosine A1 receptors.
Van Der Graaf PH; Van Schaick EA; Math-ot RA; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 1997 Nov; 283(2):809-16. PubMed ID: 9353402
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
